[Percutaneous endoscopic gastrostomy in amyotrophic lateral sclerosis patients with dysphagia. A preliminary report].
Percutaneous endoscopic gastrostomy (PEG) has been proposed as symptomatic treatment of dysphagia in amyotrophic lateral sclerosis (ALS) patients. The aim of our study was to assess the safety and complications and survival after PEG implantations in 13 ALS patients. We discuss the factors related to survival in two groups: dead (6 out of 13 patients) and alive (7 out of 13) after PEG implantations. We demonstrate that the PEG procedure is quite safe and forced vital capacity (FVC) is a major factor related to survival after PEG implantation in studied patients.
Tomik
Barbara
B
Kliniki Neurologii, II Katedry i Kliniki Chirurgii Collegium Medicum UJ w Krakowie. mnbasia@softland.com.pl
Szczudlik
Andrzej
A
Bobrzyński
Andrzej
A
Budzyński
Andrzej
A
Rembiasz
Kazimierz
K
Banach
Marta
M
Pichór
Anna
A
Partyka
Dorota
D
D000368:Aged; D000369:Aged, 80 and over; D000690:Amyotrophic Lateral Sclerosis / Q000150:complications*; D003680:Deglutition Disorders / Q000209:etiology* / Q000601:surgery; D004750:Enteral Nutrition / Q000379:methods*; D005260:Female; D005773:Gastroscopy / Q000379:methods; D005774:Gastrostomy / Q000009:adverse effects* / Q000379:methods*; D006801:Humans; D008297:Male; D008875:Middle Aged; D018529:Nutritional Support; D016019:Survival Analysis; D013997:Time Factors; D016896:Treatment Outcome